Efficacy and Safety of Rituximab for Systemic Lupus Erythematosus-Associated Immune Cytopenias. A Multicenter Retrospective Cohort Study of 71 Adults

American Journal of Hematology - United States
doi 10.1002/ajh.24999

Related search